The nephron is composed of distinct segments that perform unique physiological functions. Little is known about how multipotent nephron progenitor cells differentiate into different nephron segments. it is well known that β-catenin signaling regulates the maintenance and commitment of mesenchymal nephron progenitors during kidney development. However, it is not fully understood how it regulates nephron segmentation after nephron progenitors undergo mesenchymal-to-epithelial transition. To address this, we performed β-catenin loss-of-function and gain-of-function studies in epithelial nephron progenitors in the mouse kidney. Consistent with a previous report, the formation of the renal corpuscle was defective in the absence of β-catenin. Interestingly, we found that epithelial nephron progenitors lacking β-catenin were able to form presumptive proximal tubules but that they failed to further develop into differentiated proximal tubules, suggesting that β-catenin signaling plays a critical role in proximal tubule development. We also found that epithelial nephron progenitors lacking β-catenin failed to form the distal tubules. Expression of a stable form of β-catenin in epithelial nephron progenitors blocked the proper formation of all nephron segments, suggesting tight regulation of β-catenin signaling during nephron segmentation. This work shows that β-catenin regulates the formation of multiple nephron segments along the proximo-distal axis of the mammalian nephron.
Results
Lineage analysis with Osr2Cre in the developing mouse kidney. In order to investigate the role of β-catenin signaling in mammalian nephron segmentation, we set out to perform β-catenin LOF studies, specifically targeting the epithelial nephron progenitors in the mouse kidney. Since β-catenin is ubiquitously expressed in the kidney 4 , the specificity of Cre is important. Wnt4GFPcre (Wnt4 tm3(EGFP/cre)Amc or Wnt4 tm2(EGFP/cre)Svo ) 24, 25 and Pax8Cre (Pax8 tm1(cre)Mbu ) 26 are widely used to target nephron tubules. However, the expression of these Cre lines is not exclusive to the developing nephron tubules; Wnt4GFPcre also targets the medullary stroma 27 and a subset of MNPs 11, 28, 29 while Pax8Cre targets the collecting duct in addition to the nephron lineage 30 . Removal of β-catenin from these non-nephron tubule cells may indirectly affect nephron segmentation. Therefore, we chose to use Osr2Cre (Osr2 tm2(cre)Jian ) which was previously shown to target developing nephrons in the mouse kidney 31 . To examine when Osr2Cre is activated and which nephron segments it targets, we performed lineage analysis employing Cre-mediated activation of a Rosa reporter (Ai3, Gt(ROSA)26Sor tm3(CAG-EYFP)Hze ) 32 . We found that Osr2Cre labeled mature RV and the comma-shaped body, but not nascent RV, with the Rosa reporter ( Figure S2 ). In the SSB, Osr2Cre targeted the proximal and medial segments but not the distal segment (Fig. 1A) . To determine which nephron segments these Rosa reporter-positive cells in the SSB develop into, we performed co-immunostaining of EYFP and nephron segmentation markers. We found that the Rosa reporter was active in the podocytes, the Bowman's capsule, PT, and LOH ( Fig. 1B-D) but that it was inactive in the DT (Fig. 1B) . Furthermore, we found that, unlike Wnt4GFPcre or Pax8Cre, Osr2Cre did not target MNPs, medullary stroma, or the CD (Fig. 1E ). These data showed that Osr2Cre specifically targets all nephron segments except for the DT. We noticed that Osr2Cre mosaically targeted Wt1+ cells in the nascent nephrons in the nephrogenic zone ( Figure S3 ) but that Osr2Cre labeled most of the Wt1+ cells in glomeruli with the Rosa reporter ( Figure S3 ). This result suggests that Osr2Cre may not target the proximal and medial segments of the SSB simultaneously.
We generated the β-catenin LOF mutant kidney with Osr2Cre and examined the presence of β-catenin in the SSB. In the control kidney, β-catenin was ubiquitously expressed in the SSB (Fig. 1F ). Consistent with Osr2Cre-mediated activation of the Rosa reporter in the SSB (Fig. 1A) , we found that, in the β-catenin LOF mutant kidney, the proximal and medial segments of the SSB contained considerably less β-catenin ( Fig. 1G ). Removal of β-catenin from the proximal segment of SSB was comparable to that from the medial segment. This allowed us to investigate how β-catenin regulates the development of SSB into the proximal nephron segments including podocytes, PT, and LOH. β-catenin is required for the proper formation of the renal corpuscle. To determine how loss of β-catenin in the SSB affects the development of nephron segments, we examined nephron segmentation markers in the β-catenin LOF mutant kidney with Osr2Cre (Ctnnb1 c/c ;Osr2 IresCre/+ ) and its control (Ctnnb1 c/+ ;Osr2 IresCre/+ ) kidney. We used Wt1, Lotus tetragonolobus lectin (LTL), and Slc12a1 to mark podocytes, PT, and LOH, respectively. We found that all of those nephron segments were present in the mutant kidney ( Fig. 2A-C ), suggesting that the initial specification of the nephron segments occurred in the absence of β-catenin.
To confirm that β-catenin was removed from each nephron segment in the mutant kidney, we examined the expression of β-catenin along with nephron segmentation markers. We found that, in the mutant kidney, these nephron segmentation marker-positive cells contained considerably less β-catenin compared to their counterparts in the control kidney ( Fig. 2A-C) , showing that the β-catenin gene (Ctnnb1) was indeed deleted by Osr2Cre. Our results suggest that β-catenin is dispensable for the initial specification of podocytes, PT, and LOH during nephron development. We also found that Slc12a3+ DT cells were present in the mutant kidney ( Fig. 2D ) but, since the DT cells were not targeted by Osr2Cre (Fig. 1B) , these cells were still positive for β-catenin in the mutant kidney ( Fig. 2D ).
We observed a defective formation of the renal corpuscle in the β-catenin LOF mutant kidney by Osr2Cre. In the control kidney, Wt1+ podocytes surrounded Pecam1 + endothelial cells in the renal corpuscle ( Fig. 3A) . However, in the β-catenin mutant kidney, endothelial cells failed to populate inside the renal corpuscle and podocytes failed to form the single cell layered crescent configuration characteristic of a normal renal corpuscle (Fig. 3A ). In addition, we found that expression of Akap12, a marker for parietal epithelial cells (also known as SSeCKS) 33 , was considerably reduced in the mutant kidney. This result is consistent with a previous report, which showed that removal of β-catenin in renal epithelial cells by Pax8Cre causes defects in the gross architecture of glomeruli 22 . www.nature.com/scientificreports www.nature.com/scientificreports/ To assess if the aberrant formation of the renal corpuscle seen in the β-catenin LOF mutant kidney by Osr2Cre is caused by a defect in the early specification of visceral epithelial cells (presumptive podocyte progenitors) or parietal epithelial cells (presumptive Bowman's capsule progenitors), we examined the SSB stage. We found that, in both control and mutant SSBs, endothelial cells migrated into the vascular cleft which was formed by the proximal and medial segments of the SSB, suggesting that β-catenin is dispensable for the visceral epithelial cells to recruit endothelial cells ( Fig. 3B ). In the proximal segment of the SSB, the visceral and parietal epithelial cells showed distinct cell morphologies and differential gene expression. The visceral epithelial cells were organized in a columnar manner while the parietal epithelial cells were arranged in a thin end-to-end pattern ( Fig. 3B ). Furthermore, the visceral epithelial cells expressed Wt1 and Mafb, two genes required for podocyte development [34] [35] [36] , while the parietal epithelial cells expressed Wt1, but not Mafb (Fig. 3B ). We found that the visceral and parietal epithelial cells lacking β-catenin showed normal cell morphologies and gene expression in the SSB (Fig. 3B ). Our results show that β-catenin is dispensable for the initial specification of visceral and parietal epithelial cells in the SSB. β-catenin is required for presumptive proximal tubules to develop into differentiated proximal tubules. Previously, we have shown that, in the developing mouse kidney, presumptive PT cells show weak LTL staining while differentiated PT cells show strong LTL staining and that presumptive PT cells lacking Hnf4a, a gene encoding a transcription factor specifically expressed in PT cells in the kidney, fail to develop into differentiated PT cells 37 . We found that the PT cells present in the β-catenin LOF mutant kidney showed substantially weaker LTL staining compared to the PT cells found in the control kidney ( Fig. 2B ). Since weak LTL staining of PT cells in the β-catenin LOF mutant kidney was reminiscent of the phenotype seen in the Hnf4a mutant kidney, we examined if presumptive PT cells in the β-catenin LOF mutant kidney failed to develop into differentiated PT cells. It has been reported that Cdh6 is expressed in presumptive PT cells and that its expression is downregulated in LTL-stained PT cells, suggesting that Cdh6 marks PT progenitor cells 38 . Consistent with this, we found an inverse correlation between Cdh6 expression and LTL staining in the control kidney ( Fig. 4 ). In addition, we found that both Cdh6-positive cells and LTL-stained cells expressed Hnf4a, a transcription factor specifically expressed in the PT cells 3 and required for PT development 37 . Downregulation of Cdh6 was accompanied by robust LTL staining and increased distance between Hnf4a+ nuclei, suggesting the maturation and enlargement of PT cells ( Fig. 4 ). Collectively, these observations suggest that Cdh6 is a marker for presumptive PT cells. We found that, in the β-catenin LOF mutant kidney, most of the Hnf4a+ cells showed strong Cdh6 signal and shorter internuclei distance, indicating that they are presumptive PT cells ( Fig. 4 and Figure S4A ). The mutant kidney failed to form Hnf4a+ cells with strong LTL staining nor do they express Slc5a2, a mature PT marker gene encoding a sodium-glucose cotransporter ( Figure S4B ), suggesting that presumptive PT cells lacking β-catenin fail to develop into differentiated PT cells. Our results show that β-catenin is required for presumptive PT cells to further develop into differentiated PT cells. β-catenin is required for the formation of the distal tubules. Since Osr2Cre does not target the DT cells, it does not allow us to investigate how Wnt/β-catenin signaling regulates the formation of DT. To address this, we generated the β-catenin LOF mutant kidney (Ctnnb1 c/c ;Wnt4 GFPcre/+ ) using Wnt4GFPcre www.nature.com/scientificreports www.nature.com/scientificreports/ (Wnt4 tm3(EGFP/cre)Amc ) 24 . We have previously shown that Wnt4GFPcre can target the nephron lineage including DT 11 but since Wnt4GFPcre also targets the medullary stroma 27 , Wnt4GFPcre may not be suitable for studying the role of β-catenin in LOH because removal of β-catenin in the medullary stroma may affect the development of the adjacent LOH 39 . However, this is less of a concern for studying the DT because the DT cells are located close to the cortical region of the developing mouse kidney, away from the medullary stroma.
Consistent with our observation that PT development was arrested in the β-catenin LOF mutant kidney by Osr2Cre (Fig. 4) , the β-catenin LOF mutant kidney by Wnt4GFPcre also showed fewer PT cells and weaker LTL staining ( Fig. 5A ). In the control kidney, Slc12a1+ cells elongated toward the papilla region, forming the characteristic LOH structure. By contrast, in the β-catenin LOF mutant kidney by Wnt4GFPcre, Slc12a1+ cells failed to elongate, stunting the development of the papilla (Fig. 5A ). Considering the fact that the β-catenin LOF mutant kidney by Osr2Cre showed relatively normal LOH formation ( Fig. 2A) , the failed elongation of LOH seen in Fig. 5A was likely to be caused by removal of β-catenin in the medullary stroma by Wnt4GFPcre.
When Ctnnb1 was deleted with Wnt4GFPcre, we found that the mutant kidney formed considerably fewer DT cells as marked by Slc12a3, a DT-specific transporter 3 ( Figure S5) . Interestingly, the few detectable DT cells found in the mutant kidney were positive for β-catenin ( Fig. 5B and Figure S5 ), suggesting that these cells had escaped Wnt4GFPcre-mediated removal of β-catenin. The absence of β-catenin-negative, Slc12a3-positive DT cells in the mutant kidney suggests that β-catenin signaling is required for the formation of the DT. expression of a stable form of β-catenin in the developing nephron blocks proper nephron segmentation. Our β-catenin LOF studies suggest that β-catenin regulates the development of multiple nephron segments in epithelial nephron progenitors. To further explore the mechanism of β-catenin-mediated nephron development, we performed a β-catenin GOF study using Wnt4GFPcre or Osr2Cre. The conditional allele used in this study has the third exon of the Ctnnb1 gene flanked by two LoxP sites (Ctnnb1 ex3 ) 40 . Since the third exon encodes the N-terminus of β-catenin protein, Cre-mediated recombination results in the production of an N-terminally truncated β-catenin which is resistant to degradation. Increased abundance of β-catenin leads to the activation of canonical Wnt signaling in a ligand-independent manner 40 .
We found that Wnt4GFPcre-mediated activation of a stable form of β-catenin blocked the formation of all nephron segments (Fig. 6 ). No glomeruli, PT, LOH, or DT were found in the mutant kidney. Similarly, we found that the β-catenin GOF mutant kidney by Osr2Cre lacked glomeruli and PTs ( Figure S6 ). Slc12a1+ LOH cells and Slc12a3+ DT cells were present in the β-catenin GOF mutant kidney but they failed to elongate or form normal LOH or DT segments ( Figure S6 ). Given that Osr2Cre does not target DT, it was unexpected that Slc12a3+ DT cells were reduced in this mutant (see Discussion). We found no evidence that constitutive activation of Wnt/β-catenin signaling in the developing nephrons promoted the formation of any specific nephron segment. Instead, we found that expression of a stable form of β-catenin in the developing nephron inhibited the formation of all nephron segments.
To investigate how expression of a stable form of β-catenin interferes with nephron segmentation, we examined early development of the nephron in the β-catenin GOF mutant kidney by Wnt4GFPcre. In the control kidney, the proximal and medial segments of the SSB were marked by Wt1 and Jag1, respectively, and the expression domains of Wt1 and Jag1 did not overlap, showing clear separation (Fig. 7A ). By contrast, in the β-catenin GOF mutant kidney, we observed an overlap of the Wt1 expression domain and the Jag1 expression domain. Although the initial morphology of the SSB appeared relatively normal in the β-catenin GOF mutant kidney, the Jag1 expression domain expanded aberrantly toward the Wt1 expressing proximal segment of the SSB (Fig. 7A ). This result shows that the β-catenin GOF mutant kidney by Wnt4GFPcre exhibits a defect in nephron segmentation as early as the SSB stage. We observed a similar phenotype in the β-catenin GOF mutant kidney by Osr2Cre ( Figure S7A) .
One of the most striking defects seen in the β-catenin GOF mutant kidney by Osr2Cre or Wnt4GFPcre was the complete lack of LTL + PTs ( Fig. 6A and Figure S6 ). Since Hnf4a plays a critical role in PT development 37 , we examined Hnf4a expression in the β-catenin GOF mutant kidney. In the nephron lineage of the control kidney, Pax2 expression was mostly restricted to the nephrogenic zone at the cortex, marking the cap mesenchyme and nascent developing nephrons (Fig. 7B ). In the control kidney, Pax2 was undetectable in most of the Hnf4a+ PT cells, suggesting that the formation of PTs is accompanied by downregulation of Pax2 (Fig. 7B ). Interestingly, we found that, in the β-catenin GOF mutant kidney by Wnt4GFPcre, all Hnf4a+ cells were positive for Pax2 ( Fig. 7B ). Pax2 expression was not restricted to the nephrogenic zone in the mutant kidney. Instead, most of the epithelial structures found in the mutant kidney showed persistent expression of Pax2 (Fig. 7B ), suggesting that epithelial nephron progenitors experiencing persistent β-catenin activity are developmentally arrested, failing to further differentiate into PTs. Taken together, our results suggest that tight regulation of β-catenin signaling is required for the proper patterning of the nephron even after initial commitment of nephron progenitors. We observed a similar phenotype in the β-catenin GOF mutant kidney by Osr2Cre ( Figure S7B ). 
Discussion
β-catenin is known to regulate the maintenance and commitment of the MNPs 17-21 . Here we show that it continues to play critical roles in nephron development after the initial commitment of nephron progenitors. Strikingly, we found that, in epithelial nephron progenitors, β-catenin signaling regulates the development of multiple nephron segments without promoting the formation of any specific segment.
Little is known about how multipotent MNPs develop into different nephron segments during kidney development 1,2 . The first sign of nephron segmentation can be seen as early as the renal vesicle (RV) stage 24, 38, 41, 42 . The distal part of the RV (the part closer to the branching tip of the collecting duct) shows differential gene expression compared to the rest of the RV ( Figure S1A ). We have previously identified multiple β-catenin-bound enhancers that are associated with genes activated during differentiation of MNPs 19 . Transgenic analyses in the developing mouse kidney revealed that these enhancers were active in the distal RV but inactive in the proximal RV 19 . In addition, we have previously shown that the expression of Jag1 in the distal RV was correlated with the downregulation of Six2 while Six2 was still detectable in the proximal RV 10 . The cellular identity of the MNPs appears closer to that of the proximal RV than that of the distal RV, consistent with a recent finding that the cells in the proximal RV exit from the cap mesenchyme later than the cells of the distal RV 43 .
By the time the RV is transformed into the SSB, three discrete (proximal, medial and distal) segments are established 2 (Figure S1A ). The proximal segment of the SSB is thought to develop into the renal corpuscle because it expresses podocyte marker genes such as Wt1 and Mafb (Fig. 3B ). The distinct cell morphologies of the two cell layers in this segment suggest that the visceral and parietal epithelial cells develop into podocytes and Bowman's capsule, respectively. The fact that Osr2Cre targets the medial segment, but not the distal segment, of the SSB helped us reveal that the medial segment develops into PT and LOH. This is consistent with our previous report that Hnf4a, a transcription factor required for the PT development, was detected in the proximal subset of the medial segment of the SSB 37 and suggests that Hnf4a-negative cells in the distal subset of the medial segment develop into LOH. This then allowed us to infer that the distal segment of the SSB develops into the DT. Our lineage analysis with Osr2Cre uncovered a correlation between SSB segments and mature nephron segments. www.nature.com/scientificreports www.nature.com/scientificreports/ Lindström et al. have suggested that a gradient of β-catenin activity regulates segmentation in the nascent nephron 23 . They manipulated Wnt/β-catenin signaling pharmacologically in the embryonic kidney explant which is suitable for studying early nephrogenesis rather than the formation of mature nephron segments. They mainly focused on how β-catenin regulates the formation of different segments in the SSB. It is unclear how the altered segmentation of the SSB influences the segmentation of the fully formed nephron. Unlike the pharmacological approach which targets every cell in the kidney explant in vitro, our genetic approach allowed us to specifically target epithelial nephron progenitors and their descendants in vivo. Although Osr2Cre is active in the mature RV ( Figure S2 ), one has to consider that there is lag time between Cre-mediated recombination and the intended effects; degradation of Ctnnb1 mRNA and β-catenin protein must occur in order to achieve removal of β-catenin while the production of a stable form of β-catenin requires transcription and translation after Cre removes the third exon of Ctnnb1. Hence, our genetic approach may not be suitable for studying the role of β-catenin on the transformation of RV into SSB. Since the initial formation of SSB appears relatively normal in both β-catenin loss-of-function and gain-of-function mutant kidneys, we think that the effects of genetic manipulation of β-catenin reported in this work mainly reflects how β-catenin regulates the development of SSB into mature nephron segments.
Since the β-catenin LOF mutants by Osr2Cre die shortly after birth with severe craniofacial defects 44 , we could not analyze the mutant kidney postnatally. By contrast, the β-catenin LOF mutants by Pax8Cre show no lethality until 2 weeks of age 22 . In the kidney, Pax8Cre targets DT and CD in addition to the nephron segments targeted by Osr2Cre. Previous electron microscopy analysis of the β-catenin LOF mutant kidney by Pax8Cre showed a glomerulogenesis defect similar to our results shown in Fig. 3A . Furthermore, it was reported that the β-catenin LOF mutant adult kidney by Pax8Cre lacks the outermost cortex 22 , implying a similar PT defect seen in our study. However, the effects on other nephron segments were not investigated in that report.
We have previously shown that, in the absence of Hnf4a, presumptive PT cells failed to develop into differentiated PT cells, suggesting that Hnf4a is dispensable for the formation of presumptive PT cells but required for the formation of differentiated PT cells 37 . It is quite interesting that removal of β-catenin prevented presumptive PT cells from developing into differentiated PT cells, showing a similar defect seen in the Hnf4a LOF mutant kidney. A number of reports suggested a potential interaction between the Wnt/β-catenin pathway and Hnf4a [45] [46] [47] [48] [49] . Notably, it was shown that Hnf4a and β-catenin not only form a complex but also share common target genes in the liver 48 . Identification of common target genes regulated by both Hnf4a and β-catenin in presumptive PT cells would help us understand how these two factors coordinate PT development.
We found that the β-catenin LOF mutant kidney developed structures resembling LOH as judged by the expression of Slc12a1, a gene encoding a LOH-specific transporter. However, the mutant LOHs were substantially thinner compared to those found in the control kidney (Fig. 2C ). Therefore, it is possible that β-catenin regulates the maturation of LOH. Since Osr2Cre does not target the DT cells, we generated another β-catenin LOF mutant kidney using Wnt4GFPcre which does target DT 11 . We found that all the DT cells formed in the β-catenin LOF mutant kidney were positive for β-catenin ( Fig. 5 and Figure S5 ), indicating that these cells escaped Cre-mediated removal of the β-catenin gene. The absence of β-catenin-negative DT cells in the mutant kidney suggests that β-catenin is required for the formation of DT. Our result is consistent with a previous report that the distal segment of the SSB is exposed to a higher level of Wnt/β-catenin signaling than the rest of the SSB 23 . This is also supported by the fact that the β-catenin-bound enhancers identified in MNPs are active in the distal segment of the SSB 19 . Although the distal segments of the developing nephron may experience a higher level of β-catenin signaling, we found that constitutive activation of β-catenin signaling did not promote the formation of the distal segments. Instead, it blocked the proper patterning of all nephron segments ( Fig. 6 and Figure S6 ). Taking into account that the β-catenin GOF mutant cells show persistent expression of Pax2 and that they fail to activate Hnf4a expression ( Fig. 7 and Figure S7 ), it appears that constitutive activation of β-catenin signaling in epithelialized nephron progenitors results in developmental arrest. Although both Wnt4GFPcre and Osr2Cre caused developmental arrest in the β-catenin GOF mutant kidneys, these two mutants showed some slight differences. While no Slc12a1+ LOH or Slc12a3+ DT cells were formed with Wnt4GFPcre (Fig. 6 ), a very few Slc12a1+ or Slc12a3+ cells were found with Osr2Cre ( Figure S6 ). This may be due to the fact that the distal segment of the SSB can be targeted by Wnt4GFPcre, but not by Osr2Cre. It is likely that Wnt4GFPcre-mediated activation of a stable form of β-catenin in the distal segment of the SSB blocked the initial specification of DT cells. However, it is unclear why the specification of LOH cells was affected by Wnt4GFPcre, but not by Osr2Cre, despite the fact that LOH cells are derived from the medial segment which is targeted by both Cre lines. It is possible that the development of one nephron segment (e.g. LOH) partially depends on another nephron segment (e.g. DT).
Constitutive activation of Wnt/β-catenin signaling is not compatible with proper nephrogenesis. Expression of a stable form of β-catenin by Six2Cre 17 , Wnt4Cre, or Osr2Cre blocks nephrogenesis. Although apparent phenotypes may look similar in these β-catenin GOF mutant kidneys, they show different points of developmental arrest in nephrogenesis. We have previously shown that, when Six2Cre is used, the arrest occurs at the pretubular aggregate stage 17 . In contrast, when Wnt4Cre or Osr2Cre is used, the developmental arrest occurs at the epithelial nephron progenitors ( Fig. 7 and Figure S7 ). The fact that constitutive activation of β-catenin signaling causes arrest in nephrogenesis suggests that turning off the Wnt/β-catenin signaling is also critical for nephron formation. Taken together, it appears likely that transient activation of Wnt/β-catenin signaling is required at multiple steps of nephrogenesis.
Since β-catenin participates in not only canonical Wnt signaling but also cell adhesion, we cannot rule out the possibility that the phenotypes in β-catenin LOF and GOF mutant kidneys presented here are partly due to defective cell adhesion. Further investigation will be required to address this issue properly. One way is to test if deletion of genes encoding other components of the canonical Wnt pathway (such as Lrp5/Lrp6 or Tcf genes) recapitulates the β-catenin LOF mutant phenotypes. Alternatively, manipulation of genes encoding other adhesion factors would help resolve this issue. Nonetheless, considering the critical roles of Wnt/β-catenin signaling www.nature.com/scientificreports www.nature.com/scientificreports/ on cell fate determination in various biological contexts 14, 15, 50 , our genetic analyses of β-catenin is likely to represent the role of Wnt/β-catenin signaling in nephron segmentation. Overall, our data presented here suggest that β-catenin regulates the development of multiple nephron segments along the proximo-distal axis. It is likely that precise spatiotemporal activation and inactivation of β-catenin signaling is required for the proper formation of the mammalian nephron.
Methods
Mouse strains. All animal procedures were approved by the Institutional Animal Care and Use Committee at Cincinnati Children's Hospital Medical Center in accordance to their guidelines for the care and use of laboratory animals (IACUC2017-0037). Gt(ROSA)26Sor tm3(CAG-EYFP)Hze (Rosa26 Ai3 ) 32 , Wnt4 tm3(EGFP/cre)Amc (Wnt4GFPcre) 24 , Osr2 tm2(cre)Jian (Osr2Cre or Osr2 IresCre ) 31 , Ctnnb1 tm2Kem (Ctnnb1 c ) 51 , and Ctnnb1 tm1Mmt (Ctnnb1 ex3 ) 40 mice were described previously.
Immunofluorescence. Embryonic kidneys at E18.5 were fixed with 4% paraformaldehyde in PBS at room temperature for 10 min, incubated in 10% sucrose in PBS at 4 °C overnight, and imbedded in OCT. Cryosections of 10 or 12 μm were incubated in PBS containing 0.1% Triton x-100, 5% heat-inactivated sheep serum, and the following antibodies: Jag1 (TS1.15 H, rat, 1:20, Developmental Studies Hybridoma Bank), Wt1 (sc-7385, mouse IgG1, 1:100, Santa Cruz), GFP (GFP-1020, chick IgY, 1:500, Aves Labs), Slc12a3 (HPA028748, rabbit, 1:300, Sigma), LTL (FL-1321, FITC, 1:200, Vector Laboratories), Slc12a1 (18970-1-AP, rabbit, 1:200, Proteintech), β-catenin (71-2700, rabbit, 1:500, Invitrogen), β-catenin (sc-7963, mouse IgG1, 1:50, Santa Cruz), Pecam1 (sc-18916, rat, 1:300, Santa Cruz), Mafb (HPA005653, rabbit, 1:300, Sigma), Akap12 (25199-1-AP, rabbit, 1:300, Proteintech), Cdh6 (HPA007047, rabbit, 1:300, Sigma), Hnf4a (ab41898, mouse IgG2a, 1:500, Abcam), Pax2 (21385-1-AP, rabbit, 1:200, Proteintech), Slc5a2 (HPA041603, rabbit, 1:100, Sigma) Fluorophore-conjugated secondary antibodies (Thermo Fisher Scientific or Jackson ImmunoResearch Laboratories) were used at a 1:500 dilution. The Jag1 antibody developed by Spyros Artavanis-Tsakonas was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. Nuclei were stained with Hoechst 33342 before mounting. Images were acquired on a Nikon TiE microscope with Andor Zyla 4.2 camera and Lumencor Spectra X light source housed at the Confocal Imaging Core at CCHMC.
